Prefer to leave your details
Myocardial expression of CC- and CXC-chemokines and their receptors in human end-stage heart failure
As retatrutide remains an investigational medicine without full regulatory approval in the UK, it is important that any suspected side effects are reported via the MHRA Yellow Card scheme at yellowcard.mhra.gov.uk or via the Yellow Card app, in addition to informing your trial team
Some prior authorizations will ask for a list of prior anti-obesity medications that have been tried. Additionally, your healthcare provider will need to confirm that you meet the eligibility criteria for Zepbound, Dr
We offer a comprehensive approach to aesthetics and concierge care
Despite the severity of the disease, a large proportion of patients with T2D do not achieve glycaemic targets [5,6,7]